Navigation Links
US Proton Therapy Market Analysis to 2017

DUBLIN, June 24, 2013 /PRNewswire/ --

Research and Markets ( has announced the addition of the "US Proton Therapy Market Analysis to 2017" report to their offering.


According to most Oncologists, about 60% of all cancer patients undergo some sort of radiation therapy during their course of treatment. Despite advances in technology for radiation therapy, a majority of these patients suffer from side effects of traditional radiation treatment. Currently prevalent radio therapy methods like X-Ray/IMRT etc. also cost pretty high in the long run.

In this context, Proton Therapy, the latest innovation in the field of radio-oncology, answers all the problems related to radiation therapy. The technology is expected to eventually replace the traditional methods of radiotherapy in the future and thus, holds immense market potential for players in the industry.

The report, US Proton Therapy Market Analysis to 2017, presented in 30 slides, provides an extensive research and in-depth analysis of the current status and future outlook of the US proton therapy market. A thorough analysis has been carried on the various parameters concerned with the existing and upcoming proton therapy centers in the US. The report offers state-wise potential for the industry players and provides conservative market estimates till 2017.

As per our research, Procure is the leading service provider and accounts for the major chunk of proton therapy market in the US. From an equipment provider's perspective, IBA has the maximum proton accelerators installed in the facilities. The report further delves into the anticipated transformation into competitive landscape due to increase in number of players leading to highly competitive market. It also comes up with upcoming trends, such as kind of treatment room model, types of proton accelerators being installed, etc.

With core statistical information on proton therapy market, the research also provides a glimpse on the fundamental requirements for setting up a proton therapy center. It describes in detail about the different components and their role in proton therapy. The research also portrays the amount of investment required for establishing a proton therapy center based on different treatment room models.

The report, which is a result of comprehensive analysis of the market by RNCOS experts, clearly describes various aspects related to setting up a proton therapy center and also states the appropriate location for the same. Further, all important aspects of market like the current market size, forecasts, readymade account of all the players that are expected to enter the market along with various drivers, challenges, and trends are provided, making it a must read for Consultants and Companies in/planning to get in the market.

Key Topics Covered:

1. What is Proton Therapy?

2. Why is Proton Therapy Better than X-ray/IMRT?

3. Which Cancers Can be Treated?

4. How to Set-up a Proton Therapy Center?

5. Proton Therapy Centers: US Market Scenario

6. Market Dynamics

7. US Proton Therapy Centers Future Direction

8. Market Opportunity Assessment

For more information visit

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

SOURCE Research and Markets
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Proton Pharma and Rottapharm Switch to Cloud-Based Veeva CRM for its Flexibility to Meet Unique Local Needs in Greece
2. Life Technologies Begins Shipping Ion Proton System
3. Varian Medical Systems Signs Purchase Agreement with Advanced Particle Therapy LLC to Supply Technology for the Georgia Proton Treatment Center to be operated by Emory Healthcare
4. Genomic Research Service Provider DNA Link Purchases 10 Ion Proton Sequencers
5. Concord Medical Acquires Ownership Interest in MD Anderson Cancer Center Proton Therapy Center
6. Apollo Hospitals to Establish the First Proton Therapy Center for Cancer Treatment to Serve Over 3.5 Billion People
7. Pioneering Medical Technology Company, Optivus Proton Therapy, Inc., Celebrates 20th Anniversary
8. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
9. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
10. IRIDEX Introduces Non-Invasive MicroPulse™ Therapy for Glaucoma
11. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
Post Your Comments:
(Date:12/1/2015)... 1, 2015 Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a country ... drugs registered in Europe in 2015 were tested ... Russia has always been a country of choice ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 2015 , ... CloudLIMS today announced that it is the ... the New Products and Services category for its innovative product offering, BioTracer. ... that helps labs organize data and track samples with storage inventories. BioTracer's SaaS ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... ... 2015 , ... McLean, VA., December 1, 2015 - Octo ... sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) IT Services ... engineering, infrastructure, as well as operations and sustainment support to the NGA’s Agile ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as ... Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace. ...
Breaking Medicine News(10 mins):